Biotech

All Articles

Arrowhead fires off stage 3 records in unusual metabolic health condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its own hand ahead of a possible face-off along with Ionis, ...

Pfizer, Valneva show lyme health condition try successful for second enhancer

.Pfizer and also Valneva might have concerning two more years to stand by before they create the ver...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a conversation with Ayla Ellison, Strong Biotech Managing Editor and also Michell...

New data demonstrate how Bayer's asundexian fell short to prevent strokes

.Bayer put on hold the phase 3 test for its own variable XIa inhibitor asundexian behind time last y...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its various sclerosis (MS) med tolebrutinib to the FDA, e...

Galapagos' stockpile as fund reveals intent to shape its progression

.Galapagos is happening under extra stress from financiers. Having actually created a 9.9% risk in G...

Cell- focused Sana scoops very first CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings a...

Allist pays off Jacobio $21M, landing role in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually acquired on its own a starring role in China's KRAS ma...

ReNeuron leaving behind goal exchange after skipping fundraising goal

.ReNeuron has actually participated in the long checklist of biotechs to leave behind London's goal ...

MBX apply for IPO to take opposition to Ascendis right into stage 3

.MBX Biosciences has contributed to the current spurt of IPO filings. The biotech, which submitted i...